July 9, 2026
SOHO Insider Hem/Onc Library Multiple Myeloma

Multiple Myeloma News

EHA 2026 Meetings / Conferences Multiple Myeloma

Study identifies new standard of care for relapsed or refractory MM in the second line and beyond

Microscope in AI virtual pattern
ASCO 2026 Cellular Therapy Multiple Myeloma News

Anito-cel manufacturing builds on CAR T-cell learnings in multiple myeloma trials

ASCO 2026 Trending now Multiple Myeloma SOHO Insider Podcast

Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma

ASCO 2026 Trending now Meetings / Conferences Multiple Myeloma News

Dr. Hans Lee on MRNA-2808 in relapsed or refractory multiple myeloma

AACR 2026 Cellular Therapy Multiple Myeloma News Video Interviews

Drs. Ghobrial and Nadeem discuss results from the phase II CAR-PRISM trial

China flag
Leukemia Acute Myeloid Leukemia Multiple Myeloma News

China NMPA accepts IND application for novel bispecific in heme malignancies

Microscope in AI virtual pattern
SOHO 2025 Ambassador Program Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma News

Dr. Raheel Iftikhar weighs in on AI in blood cancers

IV therapy; CAR-T
AACR 2026 Cellular Therapy Multiple Myeloma News

In vivo CAR-T shows promise but safety is a concern

Anthony_Letai_800x600
AACR 2026 Cellular Therapy Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Meetings / Conferences Multiple Myeloma Myelodysplastic Syndromes News

NCI director says institute is ‘stable’ after turbulent year

Richard Pazdur_AACR_800x600
AACR 2026 Cellular Therapy Leukemia Lymphoma Meetings / Conferences Multiple Myeloma Myelodysplastic Syndromes News

Former FDA-OCE Director Richard Pazdur: ‘there is a palpable sense of anxiety at FDA’